Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments - Wikidata - wikimedia - TriplyDB

Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments

Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments

http://www.wikidata.org/entity/Q33713435

about

What you always needed to know about electroporation based DNA vaccines Anti-angiogenic gene therapy in the treatment of malignant gliomas Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines Laser-induced microbubble poration of localized single cells.Efficient single-cell poration by microsecond laser pulses.Physically facilitating drug-delivery systems.Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses.Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells.Novel vaccines to human rabies Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.Avoiding the side effects of electric current pulse application to electroporated cells in disposable small volume cuvettes assures good cell survival Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery.Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant.Expression of dog microdystrophin in mouse and dog muscles by gene therapy DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.Improvement of different vaccine delivery systems for cancer therapy.Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin Efficient electroporation of liposomes doped with pore stabilizing nisin.Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.Transfection by electroporation.A lipocentric view of peptide-induced pores.Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array.Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.Codon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7 Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids Advances in Gene Delivery Systems.Muscle gene electrotransfer is increased by the antioxidant tempol in mice HIV DNA Vaccine: Stepwise Improvements Make a Difference.Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques DNA is an efficient booster of dendritic cell-based vaccine A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies.Deinococcus radiodurans pprI expression enhances the radioresistance of eukaryotes.Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Emerging cancer vaccines: the promise of genetic vectors.

P2860

Q24602340-0DE5495A-8E89-4724-BCC1-3E5D11266722 Q26866276-B6DB0800-FAFA-4896-B945-FE3999D65529 Q26998547-AE0C32BD-997F-4763-9346-E7994B9EEE6A Q28294355-88BDB63E-37AD-4BAB-B17B-1F12A1228DD2 Q30412532-0EF5ED2F-DDE3-463D-9E42-EC95BC6A5FC0 Q30420426-04024399-5E37-475D-91C4-0B9F61E86120 Q30462003-D1CACEF7-DAF2-4373-BEDB-072C2D173AFF Q30477374-572FDEC2-7D32-48BE-ADD5-659431E5CF6D Q30614255-EBE037A8-C6ED-472F-BEBF-57BA8A0658E0 Q33497050-5E7F87F3-EF22-47D5-A3AF-CBD07BF32E2E Q33507253-51A56169-24DF-4497-B33E-FC56A287C4F4 Q33604583-993D803C-A96B-4338-9A8B-320CCE4BB546 Q33634886-F724F7E2-89BA-4FC9-BFF7-20E152A7BDFD Q33786397-EC3FF8A5-C82B-480D-A5FD-6366526E76C0 Q33832131-C78353EB-0AD4-427F-B748-05C69EED6AEA Q33850502-BEBE80E8-D73B-4016-BEF5-12557094CBD0 Q33931564-342EE518-8D6B-46DB-967A-4BF23BF210B4 Q34250318-10DDC20F-D04D-4EC5-AB15-B573283CE25F Q34506877-B5143F69-9542-428C-BA43-70C6CFDA3173 Q34621352-201AB359-2778-46B5-B79C-D3EB20B19D23 Q34675279-EDAFDBA2-81B0-4FD4-BE5C-9F77B734B3FB Q34706913-105D7A70-E00E-4ECD-A010-D2DCB9B0C512 Q34748879-53AF2F92-4474-4EF4-BCA3-9A7A6779F068 Q34757093-9CA82A2E-B6E0-49D0-BC23-1B762159B983 Q34977670-014F1D65-AFD3-48D3-9780-671521B16045 Q34994545-363362C6-A380-4AE3-8893-CB7F7459ABBF Q35066196-8DDC31FA-5DB7-45D3-8496-ED0C975C8664 Q35208290-2EBB116A-EB4E-466D-9C2A-E5579DEA5053 Q35530249-123FE601-B9F6-430B-8048-F4EEC2305185 Q35632772-4F80B75F-7045-46A9-A1B7-1A71FBDD1B62 Q35819837-006D3C01-49AD-4C21-BB0E-6C0A22E644FF Q35826742-27BB9823-4367-4B4C-B9ED-316222B4A8BB Q36256319-FDB561D6-2FFE-458E-AEC3-25218365A415 Q36256389-D2CFB838-40AD-4B3A-A3B3-F0FAD77BCDF2 Q36494733-B74DCA79-EAD3-4083-A7CC-BB7C5751AC1C Q36694825-CEB4DF4B-F77C-457F-8BF1-45D336C5B533 Q37010987-07A0BF47-8017-400C-96E4-DCCB64906C8E Q37085781-91719AFC-75B9-45A2-9BB7-CE2A41ED7037 Q37137404-8131108F-A2EA-4732-BC80-2BBF370F3845 Q37137464-503101B3-AF9E-4EE4-8DAC-46C36A28BAA3

P2860

Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments

http://www.wikidata.org/entity/Q33713435

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Electroporation for the delive ...... current clinical developments

@ast

Electroporation for the delive ...... current clinical developments

@en

type

label

Electroporation for the delive ...... current clinical developments

@ast

Electroporation for the delive ...... current clinical developments

@en

prefLabel

Electroporation for the delive ...... current clinical developments

@ast

Electroporation for the delive ...... current clinical developments

@en

P1433

Q33713435-76EFF567-F7F7-4779-A39C-43D5A9C062F6

P1476

Q33713435-20F094A9-A0F1-421B-8FD9-7A1907EE5F9C

P2093

Q33713435-CCEA44DF-8664-4457-A08F-13CE0E2C4506

Q33713435-CEBB0C53-D679-4C45-A14B-B54BCAC57E30

Q33713435-D34021CB-3DDF-47A6-8FE6-3D37F0ADAF2E

P2860

Q33713435-053E75F2-C965-4B2D-A601-825A298D987D

Q33713435-09D3C855-1EF5-40A7-8A8F-6747E2B69025

Q33713435-0A5478D7-A2FB-4BDB-A3FF-FD333D0CD615

Q33713435-0BEEDBC5-0721-421D-9672-D3E621BF7206

Q33713435-11AECFA4-BF39-4848-B8BC-71526252C527

Q33713435-11E08C7B-C66C-4FEB-B281-71206416EB3A

Q33713435-14F88975-5680-45FA-8B80-FF1DBB0ADD29

Q33713435-16989580-A093-4024-836D-7C1AAA7BDA62

Q33713435-18D2CEA0-EB34-4F32-A921-79BCC76AE1D7

Q33713435-1CE7F79A-A70B-4F3C-AFC5-A67B530D0B4D

P304

Q33713435-322DFFB2-601D-43AF-B6E4-948645EC2C5F

P31

Q33713435-C8C946C4-267E-4CCA-B7B4-0651C6F8C011

P356

Q33713435-3F9BB1D6-1853-4274-980F-B78A12BA8ABC

P433

Q33713435-C707B090-113D-4030-9B59-73DA612B57AF

P478

Q33713435-4D6394D9-4AEE-4404-8495-5AA193FBA478

P577

Q33713435-F4B0CCD2-8F30-4CAD-855E-E4118454EF68

P5875

Q33713435-745B481A-EC1B-448D-BB53-98AC284F247F

P698

Q33713435-72157315-4927-4D8F-A35F-89038CC5B96A

P921

Q33713435-1FA06967-89FD-44CF-ADC3-D30600FDB1D4

Q33713435-D4C158DD-1B3E-4C42-8F34-A1BC068FD5B6

P932

Q33713435-DC26B9D6-11DA-4282-A70A-18E4AFB43F39

P356

P1433

Molecular Therapy

P1476

Electroporation for the delive ...... current clinical developments

@en

P2093

Angela M Bodles-Brakhop

http://www.w3.org/2001/XMLSchema#string

Richard Heller

http://www.w3.org/2001/XMLSchema#string

Ruxandra Draghia-Akli

http://www.w3.org/2001/XMLSchema#string

P2860

Gene transfer into mouse lyoma cells by electroporation in high electric fields

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens.

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Electrotransfer of therapeutic molecules into tissues.

Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

P304

585-592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24021838

http://www.w3.org/2001/XMLSchema#string

P698

19223870

http://www.w3.org/2001/XMLSchema#string

P921

electroporation

P932

2835112

http://www.w3.org/2001/XMLSchema#string